Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes. [electronic resource]
Producer: 20170907Description: e0171753 p. digitalISSN:- 1932-6203
- Adamantane -- analogs & derivatives
- Adult
- Aged
- Biomarkers, Pharmacological -- blood
- Blood Glucose -- drug effects
- Diabetes Mellitus, Type 2 -- blood
- Dipeptides -- therapeutic use
- Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
- Female
- Glycated Hemoglobin -- analysis
- Health Status Indicators
- Humans
- Linagliptin -- therapeutic use
- Male
- Middle Aged
- Nitriles -- therapeutic use
- Predictive Value of Tests
- Prognosis
- Pyrrolidines -- therapeutic use
- Retrospective Studies
- Sitagliptin Phosphate -- therapeutic use
- Treatment Outcome
- Vildagliptin
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.